Abstract
Quinoxaline 1,4-dioxide derivative, 2-{[benzyl(cyanomethyl)amino]methyl}-3-(ethoxycarbonyl) quinoxaline 1,4-dioxide (Q3D), was synthesized and labeled with radioiodine via direct electrophilic substitution giving labeling yield above 90%. The product was examined by paper electrophoresis. 125I-Q3D was prepared using Chloramine T as oxidizing agent. 125I-Q3D was stable for up to 72 h post labeling, in contrast to 99mTc-AQCD which is stable only for a short time. Biodistribution study of 125I-Q3D in ascites tumor bearing mice revealed large uptake of the labeled compound in tumor sites. In addition, in vitro incubation of the labeled compound with Ehrlich cells indicated incorporation of these compounds in DNA of tumor cells. This uptake of 125I-Q3D in DNA of tumor cells may be helpful in tumor diagnosis and therapy.
Similar content being viewed by others
References
Wally, M.A., El-Gogray, S.R., and El-Sepelgy, O.Z., Synth. Commun., 2010, vol. 40, pp. 1–5.
Adelstein, S.J. and Kassis, A.I., Acta Oncol., 1996, vol. 35, no. 7, p. 797.
Kassis, A.I., Kirichian, A.M., Wang, K., et al., Int. J. Radiat. Biol., 2004, vol. 80, p. 941.
Kassis, A.I., J. Nucl. Med., 2003, vol. 44, p. 1479.
Ibrahim, I.T. and Wally, M.A., J. Radioanal. Nucl. Chem., 2010, vol. 285, pp. 169–175.
Pressacco, J., Hedley, D.W., and Erlichman, C., Cancer Res., 1994, vol. 54, p. 3772.
Mester, J., DeGoeij, K., and Sluyser, M., Eur. J. Cancer, 1996, vol. 32, p. 1603.
Issidorides, C.H. and Haddadin, M.J., J. Org. Chem., 1966, vol. 31, p. 4067.
Korde, A., Venkatesh, M., and Sarma, H.D., in Int. Symp. on Modern Trends in Radiopharmaceuticals for Diagnosis and Therapy, Lisbon (Portugal), March 30–April 3, 1998, IAEA, SM-355/13.
Walicka, M.A., Adelstein, S.J., and Kassis, A.I., Radiat. Res., 1998, vol. 149, p. 134.
Bodei, L., Kassis, A.I., Adelstein, S.J., and Mariani, G., Cancer Biother. Radiopharm., 2003, vol. 18, no. 6, p. 861.
Chen, K., Adelstein, S.J., and Kassis, A.I., Int. J. Radiat. Biol., 2004, vol. 80, nos. 11–12, p. 921.
Greene, R.F. and Collins, J.M., Cancer Res., 1990, vol. 50, p. 6652.
Coenen, H.H. and Wilbur, D.S., Bioconjugate Chem., 1992, vol. 3, p. 433.
Darnowski, J.W. and Goulette, F.A., Biochem. Pharmacol., 1994, vol. 48, p. 1797.
Noaman, E., Salem, H.A., Motaleb, M.A., et al., Arab J. Nucl. Sci. Appl., 2007, vol. 37, p. 1.
Nair, S.C., Pannikar, B., and Panikkar, K.R., Cancer Lett., 1991, vol. 57, no. 2, p. 109.
Desombre, E.R., Cancer Res., 1992, vol. 52, p. 5752.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Radiokhimiya, 2012, Vol. 54, No. 4, pp. 364–368.
The text was submitted by the authors in English.
Rights and permissions
About this article
Cite this article
Ibrahim, I.T., Waly, M.A. & El-Tawoosy, M. Synthesis, labeling, and biological evaluation of 2-{[benzyl(cyanomethyl)amino]methyl}-3-(ethoxycarbonyl)-quinoxaline 1,4-dioxide in ascites bearing mice. Radiochemistry 54, 395–400 (2012). https://doi.org/10.1134/S1066362212040157
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1066362212040157